Peter S Roddy
CIK 1233531 · SVP Finance & CAO · last filed 2018-03-01
Peter S Roddy is a SVP Finance & CAO who has filed 44 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider was granted $20 of CYTK on Mar 1, 2018. Across all open-market trades the lifetime net is −$273.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PTIE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYTK | SVP Finance & CAO | 21,520 | $55.40 | $1.19M | $0 | 1 | 2018-03-01 |
| Aspira Women's Health Inc. (VRML) Delisted | Director | 181,334 | — | — | $23.8K | 9 | 2016-04-19 |
| CASSAVA SCIENCES INC (PTIE) Delisted | Chief Financial Officer | 17,354 | — | — | -$297.6K | 34 | 2016-04-15 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-01 | CYTK | Grant (A) | +20,000 | $20 | EDGAR |
| 2016-04-19 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +33,182 | $0 | EDGAR |
| 2016-04-15 | CASSAVA SCIENCES INC (PTIE) Delisted | Grant (A) | +18,386 | $0 | EDGAR |
| 2016-03-21 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +47,403 | $0 | EDGAR |
| 2015-12-15 | CASSAVA SCIENCES INC (PTIE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-15 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +26,340 | $0 | EDGAR |
| 2014-12-23 | Aspira Women's Health Inc. (VRML) Delisted | Buy (P) | +16,502 | $23.8K | EDGAR |
| 2014-11-18 | CASSAVA SCIENCES INC (PTIE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-15 | CASSAVA SCIENCES INC (PTIE) Delisted | Mixed | +18,541 | -$1 | EDGAR |
| 2014-03-31 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.